Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MEN1309 |
Trade Name | |
Synonyms | OBT076|OBT-076|OBT 076|MEN-1309|MEN 1309 |
Drug Descriptions |
MEN1309 (OBT076) is an antibody-drug conjugate that consists of a monoclonal CD205 antibody linked to the anti-microtubule agent, DM4, which may result in increased cytotoxicity in CD205-expressing tumor cells (PMID: 31227646, PMID: 33131247). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C165598 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Balstilimab + MEN1309 | Balstilimab MEN1309 | 0 | 1 |
MEN1309 | MEN1309 | 0 | 2 |
MEN1309 + Pembrolizumab | MEN1309 Pembrolizumab | 0 | 0 |